Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected3M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | MRNA | ABBV | GILD |
|---|---|---|---|
| Return | |||
| Last Price | 145.94 | 256.25 | 150.53 |
| Daily Change | − 1.97% | − 1.52% | − 0.46% |
| Period ReturnPast 3 Months | + 217.64% | + 20.21% | + 14.68% |
| Valuation | |||
| Market Cap | $57.9 B | $453 B | $187 B |
| P/E Ratio | — | 71.99 | — |
| Dividend Yield | — | 4.47% | 3.98% |
| Net MarginTrailing 12M | 141.4% | 9.8% | 10.6% |
| Risk | |||
| Beta | 1.22 | 0.20 | 0.40 |
| 52-Week Range | 22.28 — $176.66 | 190.75 — $267.47 | 108.46 — $157.29 |
| Company | |||
| Sector | Health Care | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Biotechnology |
Company
- MRNAHealth Care · Biotechnology
- ABBVHealth Care · Biotechnology
- GILDHealth Care · Biotechnology
Alpaca · SIPUpdated 22:4215 Minutes Delayed
To Understand This